Vinge advises Geveko Markings and Solix Group in collection with the debt financing of Geveko Markings’ acquisition of Oré Peinture with subsidiaries. The acquisition is the biggest in Geveko Markings’ almost 100-year history. Geveko Marking is a portfolio company of the Swedish investment firm Solix Group.
Vinge has advised Re:NewCell AB with the project financing of the company’s textile recycling plant in Sundsvall, Sweden. The loan facility amounts to SEK 450 million. Nordea, the Swedish Export Credit Corporation and the Finnish export credit agency Finnvera acted as lenders and guarantors.
Vinge has advised Embracer Group AB (publ) in connection with the signing of a new SEK 3,000,000,000 credit facility for, amongst other things, M&A purposes, with Nordea Bank Abp, filial i Sverige.
Vinge has advised Fastighets AB Trianon (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market.
Vinge has advised Sobro in connection with an investment in Road Rental Scandinavia AB, which is a turnkey supplier of traffic devices and equipment for barriers in conjunction with road works.
Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) in connection with its listing on Nasdaq First North Premier Growth Market (“Nasdaq First North Premier”). The prospectus was published on 6 November 2020 and the trading on Nasdaq First North Premier commenced on 19 August 2020.
Vinge has advised Lagercrantz Holding Oy in connection with the acquisition of the Finnish company Oy Esari Ab, which is one of Finland’s leading suppliers of facility cabinets and technology buildings.
Vinge is advising BHG Group AB (publ) in connection with the acquisition of 97.6 per cent of the shares in Nordic Nest Group AB. The acquisition price corresponds to an enterprise value of SEK 1.8 billion.
Roar BidCo AB has announced a public offer to the shareholders and holders of convertible bonds of Recipharm AB (publ). The offer values all outstanding shares and convertible bonds in Recipharm at approx. SEK 23.6 billion.
Latour Industries AB has announced a public offer to the shareholders of Allgon AB (publ). The offer values all outstanding shares in Allgon at approx. SEK 604 million.
Vinge is advising Medivir AB (publ) in connection with a rights issue which will provide Medivir with issue proceeds amounting to a maximum of SEK 170 million, as well as with an over-allotment option by way of a directed share issue of a maximum of approximately SEK 25 million.
